Campbell Wealth Management Makes New $318,000 Investment in Danaher Co. (NYSE:DHR)

Campbell Wealth Management acquired a new stake in Danaher Co. (NYSE:DHR) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,145 shares of the conglomerate’s stock, valued at approximately $318,000.

Several other institutional investors and hedge funds have also modified their holdings of DHR. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher during the second quarter worth $25,000. nVerses Capital LLC acquired a new stake in Danaher in the 2nd quarter worth about $25,000. MFA Wealth Advisors LLC purchased a new stake in Danaher in the 2nd quarter valued at about $51,000. Financial Connections Group Inc. acquired a new position in shares of Danaher during the 2nd quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP purchased a new position in shares of Danaher during the 1st quarter worth about $55,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DHR. Barclays dropped their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. UBS Group dropped their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. The Goldman Sachs Group lifted their target price on Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Evercore ISI upped their price target on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Finally, Stifel Nicolaus lifted their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Stock Performance

NYSE:DHR opened at $247.82 on Friday. Danaher Co. has a 1-year low of $190.95 and a 1-year high of $281.70. The stock has a market cap of $178.99 billion, a P/E ratio of 47.29, a PEG ratio of 4.45 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a 50-day moving average of $266.95 and a two-hundred day moving average of $260.37.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the prior year, the business posted $2.02 earnings per share. Danaher’s revenue for the quarter was up 3.1% on a year-over-year basis. On average, research analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Insider Buying and Selling at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.